The synthetic version (BPC-157) is designed to mimic and enhance the regenerative and protective effe
There should be no signs of surgical complications such as severe abdominal pain, fever, infection, or digestive problems
Patients prescribed GLP-1RAs displayed a significantly reduced hazard ratio for the diagnosis of intestinal obstruction compared with patients prescribed insulin at 1, 3, and 5 years
Pfizer secured global rights to YP05002, an oral small-molecule GLP-1 from YaoPharma/Fosun (up to ~$1.9B)
Accompanying symptoms like dizziness or abdominal pain require immediate medical attention
Contact your GP if natural approaches have not improved metabolic health after 3-6 months, if you have type 2 diabetes or pre-diabetes (HbA1c 42-47 mmol/mol), or if you struggle with obesity-related complications